Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function.
Eckhard
Michael
M
3rd Medical Department, Center of Internal Medicine, University Hospital, Rodthohl 6, D-35385 Giessen, Germany. michael.eckhard@innere.med.uni-geissen.de
Martin
I
I
Eich
T
T
Weimer
R
R
Zinn
S
S
Bretzel
R G
RG
Brendel
M D
MD
D002096:C-Peptide / Q000097:blood; D003587:Cytomegalovirus / Q000302:isolation & purification / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival / Q000502:physiology*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D011183:Postoperative Complications / Q000821:virology*; D014184:Transplantation, Homologous; D014779:Virus Replication
D002096:C-Peptide; D007166:Immunosuppressive Agents